Suppr超能文献

Sirt1 通过激活 PPARγ 抑制痛风性关节炎。

Sirt1 inhibits gouty arthritis via activating PPARγ.

机构信息

Department of Rheumatology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.

Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.

出版信息

Clin Rheumatol. 2019 Nov;38(11):3235-3242. doi: 10.1007/s10067-019-04697-w. Epub 2019 Jul 31.

Abstract

OBJECTIVE

To identify the effects of Sirtuin 1 (Sirt1) on gouty arthritis and investigate the underlying mechanisms.

METHODS

A gouty arthritis model was established by intra-articular injection of monosodium urate (MSU, 1 mg) crystal solution into the left foot pad of C57BL/6 mice. After pretreating the gouty arthritis mice with intra-articular injection of Sirt1 agonist (Resveratrol, RSV, 20 mg/kg) or peroxisome proliferator-activated receptor γ (PPARγ) inhibitor (T0070907, 1 mg/kg), the degree of joint inflammation of the gouty arthritis mice was evaluated by clinical integration of joint inflammation and hematoxylin and eosin (H&E) staining. The mRNA expression of Sirt1 and PPARγ were determined by real-time polymerase chain reaction (PCR). The expression profiling of inflammatory cytokines and chemokines in mouse joint tissues were determined by multi-factor assay kits. Peritoneal macrophages were isolated from mice and tested the effects of RSV and/or PPARγ on pro-inflammatory cytokines secretion by PCR.

RESULTS

Sirt1 agonist significantly suppressed the onset of gouty arthritis induced by MSU and reduced the infiltration of inflammatory cells in the joints. Sirt1 agonist significantly promoted the expression of PPARγ, while decreased the expression of interleukin (IL)-1β, IL-1α, IL-6, interferon-γ (IFN-γ), monocyte chemotactic protein 1(MCP-1), tumor necrosis factor a (TNF-α), and chemokines (CXCL-1, CXCL-5, CCL-22) induced by MSU in joint tissues. After blocking PPARγ with T0070907 or by siRNA, the anti-inflammatory effect of Sirt1 agonist on gouty arthritis disappeared and the expression of pro-inflammatory molecules were not significantly reduced.

CONCLUSIONS

Sirt1 may control the acute onset of gouty arthritis in mice by inhibiting the infiltration of inflammatory cells and the secretion of pro-inflammatory molecules through PPARγ. Key Points • Sirt1 and its activator, RSV, attenuate the severity of gouty arthritis in mice. • Sirt1 inhibits the infiltration of inflammatory cells and the secretion of pro-inflammatory molecules in MSU-induced arthritis. • Sirt1 inhibits inflammation partially dependent on PPARγ.

摘要

目的

确定 Sirtuin 1(Sirt1)对痛风性关节炎的影响,并探讨其潜在机制。

方法

通过向 C57BL/6 小鼠左足底关节内注射单钠尿酸盐(MSU,1mg)晶体溶液建立痛风性关节炎模型。在对痛风性关节炎小鼠进行关节内注射 Sirt1 激动剂(白藜芦醇,RSV,20mg/kg)或过氧化物酶体增殖物激活受体γ(PPARγ)抑制剂(T0070907,1mg/kg)预处理后,通过临床关节炎症综合评分和苏木精和伊红(H&E)染色评估痛风性关节炎小鼠的关节炎症程度。实时聚合酶链反应(PCR)测定 Sirt1 和 PPARγ 的 mRNA 表达。通过多因子检测试剂盒测定小鼠关节组织中炎症细胞因子和趋化因子的表达谱。从小鼠中分离出腹腔巨噬细胞,并通过 PCR 检测 RSV 和/或 PPARγ 对促炎细胞因子分泌的影响。

结果

Sirt1 激动剂显著抑制了 MSU 诱导的痛风性关节炎的发作,并减少了关节内炎症细胞的浸润。Sirt1 激动剂显著促进了 PPARγ 的表达,同时降低了 MSU 诱导的关节组织中白细胞介素(IL)-1β、IL-1α、IL-6、干扰素-γ(IFN-γ)、单核细胞趋化蛋白 1(MCP-1)、肿瘤坏死因子-α(TNF-α)和趋化因子(CXCL-1、CXCL-5、CCL-22)的表达。用 T0070907 或 siRNA 阻断 PPARγ 后,Sirt1 激动剂对痛风性关节炎的抗炎作用消失,促炎分子的表达也没有明显降低。

结论

Sirt1 可能通过抑制炎症细胞浸润和 PPARγ 介导的促炎分子分泌来控制小鼠痛风性关节炎的急性发作。关键点• Sirt1 及其激动剂 RSV 可减轻 MSU 诱导的关节炎小鼠的关节炎严重程度。• Sirt1 抑制 MSU 诱导关节炎中炎症细胞的浸润和促炎分子的分泌。• Sirt1 部分依赖于 PPARγ 来抑制炎症。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验